CV Basics
Surgeons & Patients
Products in Play
History
Geography & Market
100

This specialty focuses on surgical treatment of the heart and blood vessels

Cardiovascular Surgery

100

This is the personality trait that makes CV surgeons excel in emergencies: staying _____

Calm (or Composed)

100

This product helps support clotting regardless of the patients coagulation profile 

Vistaseal

100

What city in the US was the first open-heart surgery performed at?

Philadelphia

100

Who's at a higher risk at a younger age to develop some form of CVD?

Males

200

The most common cardiovascular procedure worldwide

CABG (Coronary Artery Bypass Graft)

200

Adults aged ___ have some form of CVD

65+ 

200

This product is classified as the ideal wound closure system in cardiac surgery to limiting surgical site infection

Dermabond PRINEO
200

Who performed the first successful CABG?

Dr. Goetz

200

Expected number of CV related deaths by 2030

23M

300

Minimally invasive and robotic CV surgeries began gaining traction in this decade

Early 2000s 

300

Which of the following is NOT typically part of a CV patient profile: Advanced age, Obesity, Frequent sports injuries, Diabetes

Frequent sports injuries

300

What product continues to remain the gold standard for CABGs 

Prolene
300

Dr. Barnard was the first to successfully perform this surgery

First heart transplant

300
The estimated number of CV procedures in 2023

1.8M

400

What is a TAVR?

Transcatheter Aortic Valve Replacement

400

The findings in Dr. Gunga's study demonstrated Prineo reduced SSIs by what percentage?

50%

400

Everpoint compared to stainless steel needles:

__ sharper

__ stronger

__ more bend resistant 

70% sharper

38% stronger

121% more bend resistant

400

This product launched in 2011

Everpoint

400

This US region has some of the highest rates of heart disease

Southeast

500

True or False: CV surgery is declining in importance due to non-surgical therapies

False

500

How long did Dr. Salazar state he currently spends on ways to ensure proper hemostasis in his surgeries?

10 mins

500

What percentage of CV patients experience disruptive bleeding in surgery

44%

500

What year did Prolene launch?

1969

500

What is our EPA growth opportunity number in adjunctive hemostats in CV

$690M